India's API industry is evolving from volume-driven supply to value-oriented strategic partnerships in regulated markets. This transformation positions India as a trusted center for quality, compliance, and innovation in global pharmaceutical manufacturing.
Hari Kiran Chereddi, Managing Director of HRV Global Life Sciences & CEO of New Horizon Global Pharma, outlined key strategies driving this evolution toward regulated market leadership.
India's Virtual Pharma Innovation
Revolutionary operational models prioritize compliance and agility over traditional infrastructure investments, delivering superior results through strategic partnerships with USFDA-approved facilities.
"We have redefined how APIs are produced by developing India's first virtual pharmaceutical company. Our model is asset-light, compliance-first, and globally integrated. Instead of investing heavily in infrastructure, we partner with underutilized yet USFDA-approved facilities across India."
Hari Kiran Chereddi, Managing Director, HRV Global Life Sciences & CEO, New Horizon Global Pharma
AI-Driven Excellence
Advanced AI integration is revolutionizing pharmaceutical operations, with artificial intelligence serving as the core of regulatory compliance, supply chain management, and client delivery optimization.
"At HRV Global and New Horizon, artificial intelligence (AI) is not a support system—it is the core of our operations. We've created an AI-native orchestration layer designed for the complexities of regulated API sourcing, regulatory compliance, and client delivery."
Hari Kiran Chereddi, Managing Director, HRV Global Life Sciences & CEO, New Horizon Global Pharma
Strategic Vision: Beyond Manufacturing
India's evolution from "Make in India" to "Design, Regulate, and Deliver from India" represents a strategic shift toward higher-value pharmaceutical services, including affordable biologics, sustainable chemistry, and personalized medicine development.
This transformation demonstrates India's potential to lead the regulated API world through innovation, compliance excellence, and technology-driven operational models that deliver value to global pharmaceutical partners.
Read the complete analysis: From Volume to Value: How India Can Lead the Regulated API World - Chemical Today
